|
<br />
<br />1. Wodak A, Cooney A (2006). Do Needle Syringe Programs Reduce HIV Infection Among Injecting
<br />Drug Users: A Comprehensive Review of the International Evidence. Journal of Substance Use &
<br />Misuse, 41:777-813. Studies cited include: National Commission on AIDS (1991), Centers for
<br />Disease Control and Prevention (1993), General Accounting Office (1994), Office of Technology
<br />Assessment of the U.S. Congress (1995), National Institutes of Health Consensus Panel (1997),
<br />U.S. Department of Health & Human Services (2001), Institute of Medicine of the National
<br />Academy of Science (2001).
<br />2. Hurley, SF, Jolley, DJ, Kalidor, JM (1997). Effectiveness of needle-exchange programs for
<br />prevention of HIV infection. The Lancet, 348:987-991.
<br />3. The Foundation for AIDS Research, Preventing HIV and Hepatitis C Among People Who Inject
<br />Drugs: Public Funding for Syringe Services Programs Makes the Difference. Issue Brief –April
<br />2015
<br />4. Health Outcomes International (HOI), National Center for HIV Epidemiology and Clinical
<br />Research, Drummond, M (2002). Return on Investment in Needle and Syringe Programs in
<br />Australia. Canberra: Commonwealth Department of Health and Ageing.
<br />5. Klevens, R.M., et al., Evolving epidemiology of hepatitis C virus in the United States. Clin Infect
<br />Dis, 2012. 55 Suppl 1: p. S3-9.
<br />6. Koh, H.K. Viral Hepatitis: The Secret Epidemic. accessed at:
<br />http://www.hhs.gov.asl/testify/2010/06/t20100617b.html. 2010 [cited 2012 July 18].
<br />7. Chak, E., et al., Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int, 2011.
<br />31(8): p. 1090-101.
<br />8. Monterroso, ER., et al. Prevention of HIV infection in street-recruited injection drug users. The
<br />Collaborative Injection Drug User Study (CIDUS). JAIDS. 2000 Sep 1;25(1):63-70.
<br />9. Ouellet, L., Huo, D., Bailey SL. HIV risk practices among needle exchange users and nonusers in
<br />Chicago. JAIDS. 2004 Sep 1;37(1):1187-96.
<br />10. Bluthenthal RN., et al., The effect of syringe exchange use on high-risk injection drug users: a
<br />cohort study. AIDS. 2000 Mar 31; 14(5):605-11.
<br />11. Gibson DR., et al., Two-to sixfold decreased odds of HIV risk behavior associated with use of
<br />syringe exchange. JAIDS. 2002 Oct 1;31(2):237-42.
<br />12. Hagan, H., et al., An interview study of participants in the Tacoma, Washington, syringe
<br />exchange. Addiction. 1993 Dec;88(12):1691-7.
<br />13. Longshore, D., Bluthenthal, RN., Stein, MD. Needle exchange program attendance and injection
<br />risk in Providence, Rhode Island. AIDS Educ Prev. 2001 Feb;13(1):78-90
<br />14. Vlahov, D., Reductions in high-risk drug use behaviors among participants in the Baltimore
<br />needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):400-
<br />6
<br />15. Marmor, M., Drug injection rates and needle-exchange use in New York City, 1991-1996. J
<br />Urban Health. 2000 Sep;77(3):359-68
<br />16. Hurley SF1, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of
<br />HIV infection. Lancet. 1997 Jun 21; 349(9068): 1797-800
<br />17. A Comprehensive Approach: Preventing Blood-Borne Infections Among Injection Drug Users.
<br />accessed at: http://www.cdc.gov/idu/pubs/ca/comprehensive-approach.pdf
<br />18. Hagan, H., et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the
<br />Tacoma syringe exchange program. Am J Public Health. 1995 Nov; 85(11):1531-7.
|